Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith L Knutson

Showing results (1-10 of 147) with videos related to

Pageof 15
Sort By:
Current Opinion in Molecular Therapeutics|September 12, 2002
Technology evaluation: DCVax, Northwest BiotherapeuticsKeith L Knutson
Current Opinion in Investigational Drugs (London, England : 2000)|June 11, 2002
GMK (Progenics Pharmaceuticals)Keith L Knutson
Future Oncology (London, England)|June 22, 2006
Strong-arming immune regulation: suppressing regulatory T-cell function to treat cancersKeith L Knutson
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 2024
Regulation of Tumor Dendritic Cells by Programmed Cell Death 1 PathwaysKeith L Knutson
Cancer Biomarkers : Section a of Disease Markers|October 13, 2010
Antibodies in cancer immunotherapyLavakumar Karyampudi, Keith L Knutson
Cancers|October 27, 2022
Resistance to TrastuzumabSneha Vivekanandhan, Keith L Knutson
Human Immunology|June 20, 2002
Clonal diversity of the T-cell population responding to a dominant HLA-A2 epitope of HER-2/neu after active immunization in an ovarian cancer patientKeith L Knutson, Mary L Disis
Cancer Immunology, Immunotherapy : CII|May 14, 2005
Adoptive T cell therapy of solid cancersKeith L Knutson, Wolfgang Wagner, Mary L Disis
BMC Musculoskeletal Disorders|January 16, 2017
Cytokine and neuropeptide levels are associated with pain relief in patients with chronically painful total knee arthroplasty: a pilot studyJasvinder A Singh, Siamak Noorbaloochi, Keith L Knutson
Breast Disease|February 3, 2005
Peptide-based vaccines in breast cancerMary L Disis, Lupe G Salazar, Keith L Knutson
Pageof 15

Showing results (1-10 of 147) with videos related to

Sort By:
Pageof 15
Current Opinion in Molecular Therapeutics|September 12, 2002
Technology evaluation: DCVax, Northwest BiotherapeuticsKeith L Knutson
Current Opinion in Investigational Drugs (London, England : 2000)|June 11, 2002
GMK (Progenics Pharmaceuticals)Keith L Knutson
Future Oncology (London, England)|June 22, 2006
Strong-arming immune regulation: suppressing regulatory T-cell function to treat cancersKeith L Knutson
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 2024
Regulation of Tumor Dendritic Cells by Programmed Cell Death 1 PathwaysKeith L Knutson
Cancer Biomarkers : Section a of Disease Markers|October 13, 2010
Antibodies in cancer immunotherapyLavakumar Karyampudi, Keith L Knutson
Cancers|October 27, 2022
Resistance to TrastuzumabSneha Vivekanandhan, Keith L Knutson
Human Immunology|June 20, 2002
Clonal diversity of the T-cell population responding to a dominant HLA-A2 epitope of HER-2/neu after active immunization in an ovarian cancer patientKeith L Knutson, Mary L Disis
Cancer Immunology, Immunotherapy : CII|May 14, 2005
Adoptive T cell therapy of solid cancersKeith L Knutson, Wolfgang Wagner, Mary L Disis
BMC Musculoskeletal Disorders|January 16, 2017
Cytokine and neuropeptide levels are associated with pain relief in patients with chronically painful total knee arthroplasty: a pilot studyJasvinder A Singh, Siamak Noorbaloochi, Keith L Knutson
Breast Disease|February 3, 2005
Peptide-based vaccines in breast cancerMary L Disis, Lupe G Salazar, Keith L Knutson
Pageof 15